8-week Randomized, Open-label Study to Evaluate Food Effect on Efficacy and Safety of Oral Aliskiren 300 mg in Patients With Hypertension
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 589 participants.
Also called NCT01570686
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 589 participants
- Sponsor
- Registry
-
NCT01570686 -
2011-005297-36
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada, Italy, Puerto Rico, Slovakia, Spain, Taiwan
- Registry status
- Completed
Technical summary
Registry record NCT01570686. Randomized; no masking; primary purpose treatment. Start 2012-04 (registry gives no type); primary completion 2012-11 (actual). Results posted on 2014-01-01.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- 8-week Randomized, Open-label Study to Evaluate Food Effect on Efficacy and Safety of Oral Aliskiren 300 mg in Patients With Hypertension
- Condition
- Hypertension
- Intervention (Drug)
- Aliskiren
- Lead sponsor
- Novartis Pharmaceuticals
Record details
- Record id
cardio:ct-nct01570686- Content hash
632891c96c24a4f871710f0406f8ad2ffda2acdcb31ef2c517c041d8f69f8013